With its new non-GMO, THC-free line of CBD products, CV Sciences plans to make Happy Lane more broadly available to U.S. customers via new distribution channels, including the convenience store channel.
Image courtesy of CV Sciences
CV Sciences (San Diego, CA) has launched a new line of cannabidiol (CBD) products called Happy Lane. With its new non-GMO, THC-free like of CBD products, CV Sciences plans to make Happy Lane more broadly available to U.S. customers via new distribution channels, including the $650 billion convenience store channel. The line is currently available in select natural product retailers across the nation in six product SKUs and multiple delivery formats, including softgels, liquids, roll-ons, chews and gummies. Happy Lane will be available in distinctive new flavors such as Berry Extraordinary, Cherry Jubilee and Peppermint Magic, with additional innovations in development.
“We are thrilled to introduce Happy Lane to expand our sales channels and bring the highest quality CBD to fulfill CV Sciences’ mission to provide all consumers with access to high quality hemp derived CBD that has been verified to be safe and effective. Happy Lane allows us to expand our sales channels to bring the CV Sciences’ quality and scientific standards to a broader audience at value,” said Joseph Dowling, chief executive officer of CV Sciences, in a press release. “With new retail distribution focused on value channels, we look forward to building long-term brand affinity with Happy Lane customers who did not previously have access to safe and effective CBD that is grown, extracted, manufactured, and lab verified by a trusted brand with a proven track record. Our initial launch of THC-free Happy Lane™ products are all available for less than $20, an entry point we believe provides access to new CBD customers.”
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.